Terms: = Skin cancer AND KMT2C, ENSG00000055609, MLL3, 58508
26 results:
1. Establishment and Characterization of a TP53-Mutated Eyelid Sebaceous Carcinoma Cell Line.
Gu X; Huang Z; Chen J; Luo Y; Ge S; Jia R; Song X; Chai P; Xu S; Fan X
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):16. PubMed ID: 38095907
[TBL] [Abstract] [Full Text] [Related]
2. Genomic landscape of multiple Bowen's disease using whole-exome sequencing.
Kim YS; Park GS; Bang CH; Chung YJ
J Dermatol; 2023 Mar; 50(3):397-400. PubMed ID: 36117467
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas.
Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N
Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970
[TBL] [Abstract] [Full Text] [Related]
4. Genomic alterations of dermatofibrosarcoma protuberans revealed by whole-genome sequencing.
Peng C; Jian X; Xie Y; Li L; Ouyang J; Tang L; Zhang X; Su J; Zhao S; Liu H; Yin M; Wu D; Wan M; Xie L; Chen X
Br J Dermatol; 2022 Jun; 186(6):997-1009. PubMed ID: 35441365
[TBL] [Abstract] [Full Text] [Related]
5. kmt2c is a Potential Biomarker of Anti-PD-1 Treatment Response in Metastatic Melanoma.
Xie K; Peng Y; Zhong W; Liu X
Front Biosci (Landmark Ed); 2022 Mar; 27(3):103. PubMed ID: 35345335
[TBL] [Abstract] [Full Text] [Related]
6. NGS Analysis Confirms Common
Peterson C; Moore R; Hicks JL; Morsberger LA; De Marzo AM; Zou Y; Eberhart CG; Campbell AA
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445161
[TBL] [Abstract] [Full Text] [Related]
7. Transposon mutagenesis identifies cooperating genetic drivers during keratinocyte transformation and cutaneous squamous cell carcinoma progression.
Aiderus A; Newberg JY; Guzman-Rojas L; Contreras-Sandoval AM; Meshey AL; Jones DJ; Amaya-Manzanares F; Rangel R; Ward JM; Lee SC; Ban KH; Rogers K; Rogers SM; Selvanesan L; McNoe LA; Copeland NG; Jenkins NA; Tsai KY; Black MA; Mann KM; Mann MB
PLoS Genet; 2021 Aug; 17(8):e1009094. PubMed ID: 34398873
[TBL] [Abstract] [Full Text] [Related]
8. Investigation of Genetic Mutations in High-risk and Low-risk Basal Cell Carcinoma in a Non-Caucasian Population by Whole Exome Sequencing.
Kim HJ; Lee M; Lee YB; Yu DS
Acta Derm Venereol; 2021 May; 101(5):adv00458. PubMed ID: 33928395
[TBL] [Abstract] [Full Text] [Related]
9. The Molecular Landscape of Primary Acral Melanoma: A Multicenter Study of the Italian Melanoma Intergroup (IMI).
Elefanti L; Zamuner C; Del Fiore P; Stagni C; Pellegrini S; Dall'Olmo L; Fabozzi A; Senetta R; Ribero S; Salmaso R; Mocellin S; Bassetto F; Cavallin F; Tosi AL; Galuppini F; Dei Tos AP; Menin C; Cappellesso R
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917086
[TBL] [Abstract] [Full Text] [Related]
10. Analysis of mutations in cutaneous squamous cell carcinoma reveals novel genes and mutations associated with patient-specific characteristics and metastasis: a systematic review.
Lobl MB; Clarey D; Schmidt C; Wichman C; Wysong A
Arch Dermatol Res; 2022 Sep; 314(7):711-718. PubMed ID: 33735396
[TBL] [Abstract] [Full Text] [Related]
11. Pediatric blastic plasmacytoid dendritic cell neoplasm: report of four cases and review of literature.
Liao C; Hu NX; Song H; Zhang JY; Shen DY; Xu XJ; Tang YM
Int J Hematol; 2021 May; 113(5):751-759. PubMed ID: 33392975
[TBL] [Abstract] [Full Text] [Related]
12. Unbiased Detection of Driver Mutations in Extramammary Paget Disease.
Ishida Y; Kakiuchi N; Yoshida K; Inoue Y; Irie H; Kataoka TR; Hirata M; Funakoshi T; Matsushita S; Hata H; Uchi H; Yamamoto Y; Fujisawa Y; Fujimura T; Saiki R; Takeuchi K; Shiraishi Y; Chiba K; Tanaka H; Otsuka A; Miyano S; Kabashima K; Ogawa S
Clin Cancer Res; 2021 Mar; 27(6):1756-1765. PubMed ID: 33323405
[TBL] [Abstract] [Full Text] [Related]
13. Presence and prevalence of UV related genetic mutations in uveal melanoma: similarities with cutaneous melanoma.
Goh AY; Ramlogan-Steel CA; Jenkins KS; Steel JC; Layton CJ
Neoplasma; 2020 Sep; 67(5):958-971. PubMed ID: 32305056
[TBL] [Abstract] [Full Text] [Related]
14. Exome sequencing identifies novel mutation signatures of UV radiation and trichostatin A in primary human keratinocytes.
Shen Y; Ha W; Zeng W; Queen D; Liu L
Sci Rep; 2020 Mar; 10(1):4943. PubMed ID: 32188867
[TBL] [Abstract] [Full Text] [Related]
15. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
16. Several genotypes, one phenotype: PIK3CA/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network.
Pfarr N; Allgäuer M; Steiger K; Weichert W; Schirmacher P; Noske A; Stenzinger A
Pathology; 2019 Jun; 51(4):362-368. PubMed ID: 31010589
[TBL] [Abstract] [Full Text] [Related]
17. Whole-Exome Sequencing Reveals Frequent Mutations in Chromatin Remodeling Genes in Mammary and Extramammary Paget's Diseases.
Zhang G; Zhou S; Zhong W; Hong L; Wang Y; Lu S; Pan J; Huang Y; Su M; Crawford R; Zhou Y; Mai R
J Invest Dermatol; 2019 Apr; 139(4):789-795. PubMed ID: 30905357
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning.
Huang J; Qian Z; Gong Y; Wang Y; Guan Y; Han Y; Yi X; Huang W; Ji L; Xu J; Su M; Yuan Q; Cui S; Zhang J; Bao C; Liu W; Chen X; Zhang M; Gao X; Wu R; Zhang Y; Xu H; Zhu S; Zhu H; Yang L; Xu X; Zhou P; Liang Z
J Med Genet; 2019 Mar; 56(3):186-194. PubMed ID: 30567904
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
Cavalieri S; Perrone F; Miceli R; Ascierto PA; Locati LD; Bergamini C; Granata R; Alfieri S; Resteghini C; Galbiati D; Busico A; Paielli N; Patuzzo R; Maurichi A; Gallino G; Ruggeri R; Mariani L; Palla M; Licitra L; Bossi P
Eur J Cancer; 2018 Jul; 97():7-15. PubMed ID: 29734047
[TBL] [Abstract] [Full Text] [Related]
20. PD-1 inhibition in congenital pigment synthesizing metastatic melanoma.
Weyand AC; Mody RJ; Rabah RM; Opipari VP
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28675691
[TBL] [Abstract] [Full Text] [Related]
[Next]
